| - SMTL ID
- 4b95.1
- Ligands
- ACETATE ION; (2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 4b95.2
- Ligands
- (2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 4b95.3
- Ligands
- (2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 4b95.4
- Ligands
- (2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|